Report : South and Central America Arrythmia Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telemetry, and Others), Application (Bradycardia, Tachycardia, Atrial Fibrillation, Ventricular Fibrillation, Premature Contraction, and Others), and End User (Hospitals and Clinics, Ambulatory Centers, Diagnostic Centers, and Others)
Hospitals and Clinics Segment to Dominate SCAM Arrythmia Monitoring Devices Market during 2020–2028
According to a new market research study on “SCAM Arrythmia Monitoring Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Application, and End User,” is expected to reach US$ 505.34 million by 2028 from US$ 342.22 million in 2021. The market is estimated to grow at a CAGR of 5.7% from 2021 to 2028. The report provides trends prevailing in the SCAM arrythmia monitoring devices market along with the drivers and restraints pertaining to the market growth. High penetration in developing nations is the major factor driving the growth of the SCAM arrythmia monitoring devices market. However, high cost of products and procedures hinder the growth of SCAM arrythmia monitoring devices market.
The arrhythmia monitoring devices market in the South and Central America includes the Brazil, Argentina, and other South American countries. The South America has reported 31.8 million cases as of June 23, 2021. The number of growing COVID-19 cases has been reported, such as, Brazil (18,056,639), Argentina (4,298,782), Columbia (3,997,021), and Chile (1,525,663). Considerable number of countries in South America have very underdeveloped healthcare infrastructure. In addition, the availability of arrhythmia monitoring in the region is also significantly lower. For instance, Peru, has less than 1000 intensive care unit beds for its 32 million inhabitants. Furthermore, supply chain disruption caused due to congestion of ports and disturbances in other transport means had substantial impact on the distribution of arrhythmia monitoring and other associated devices in the region. All these factors considerably deterred the growth of South and Central America arrhythmia monitoring devices market
The market for arrythmia monitoring devices market is segmented into type, application, end user, and country. Based on type, the market is segmented into ECG monitors, implantable monitors, holter monitors, mobile cardiac telemetry, and others. The Holter monitors segment held the largest share of the market in 2021. Based on application the arrythmia monitoring devices market is divided bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction, and others. In 2021, the atrial fibrillation segment is likely to hold the largest share of the market, however atrial fibrillation segment is expected to grow at the fastest rate during the coming years. Similarly, based on end user, the market is bifurcated into hospitals and clinics, ambulatory centers, diagnostic centers, others. The hospitals and clinics segment are likely to hold the largest share of the market in 2021, however the ambulatory centers segment is anticipated to register the highest CAGR of the market during the forecast period.
Abbott; Biotronik, Inc.; General Electric Company; Hill-Rom Holding Inc.; Koninklijke Philips N.V.; Medtronic; are among the leading companies in the SCAM arrythmia monitoring devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2019, Spacelabs Healthcare a division of OSI Systems, Inc. launched Lifescreen Pro event screening system to diagnose cardiac arrhythmias accurately and economically.
The report segments the SCAM Arrythmia Monitoring Devices Market as follows:
SCAM Arrythmia Monitoring Devices Market – By Type
- ECG Monitors
- Implantable Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
- Others
SCAM Arrythmia Monitoring Devices Market – By Application
- Bradycardia
- Tachycardia
- Atrial Fibrillation
- Ventricular Fibrillation
- Premature Contraction
- Others
SCAM Arrythmia Monitoring Devices Market – By End User
- Hospitals and Clinics
- Ambulatory Centers
- Diagnostic Centers
- Others
SCAM Arrythmia Monitoring Devices Market – By Country
- Brazil
- Argentina
- Rest of SCAM
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com